The board is tasked with assisting the ophthalmology pharmaceutical company in advancing treatment products for patients with ophthalmic diseases, according to an Aug. 2 press release. Carl Regillo, M.D., chief of retina service at Wills Eye Hospital, will chair the board.
Other board members are:
- Sophie Bakri, M.D., Mayo Clinic
- Caroline Baumal, M.D., Tufts Medical Center
- David Boyer, M.D., University of Southern California Keck School of Medicine
- Glenn Jaffe, M.D., Duke University
- Rishi Singh, M.D., Cleveland Clinic
- Charles Wykoff, M.D., Ph.D., Retina Consultants of Texas
